Radiation and Cancer Physics

SS 33 - Physics 10- Machine Learning for Planning and Segmentation

195 - An Image-Based Framework for Individualizing Radiotherapy Dose

Wednesday, September 18
12:15 PM - 12:25 PM
Location: Room W185

An Image-Based Framework for Individualizing Radiotherapy Dose
B. Lou1, S. Doken2, T. Zhuang3, D. Wingerter2, N. Mistry4, L. Ladic5, A. Kamen5, and M. Abazeed3; 1Siemens Healthineers, Malvern, PA, United States, 2Cleveland Clinic, Cleveland, OH, 3Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, 4Siemens Healthineers, Knoxville, TN, 5Siemens Healthineers, Princeton, NJ

Purpose/Objective(s): Radiotherapy continues to be delivered uniformly without taking into account individual tumor characteristics. We queried the lung computed tomography (CT)-derived feature space to identify radiation sensitivity parameters that can predict treatment failure and hence guide the individualization of radiotherapy dose.

Materials/Methods: We used a cohort-based registry of 849 patients with cancer in the lung treated with high-dose radiotherapy. We input pre-therapy lung CT images into a deep neural network, Deep Profiler, to generate an image fingerprint that primarily predicts treatment outcomes and secondarily approximates classical radiomic features. Deep Profiler was combined with electronic health records (EHR) data to derive an individualized radiation dose, iGray, a patient-specific dose that reduces treatment failure probability to <5%.

Results: Patients with high Deep Profiler scores fail radiation at a significantly higher rate than in those with low scores. The 3-year cumulative incidences of local failure were 20.3% (95% CI: 16.0-24.9) and 5.7% (95% CI: 3.5-8.8), respectively. Deep Profiler independently predicted local failure (hazard ratio 1.65, 95% 1.02-2.66, p=.042). Models that included Deep Profiler and EHR predicted treatment failures with a concordance index of 0.721, a significant improvement compared to classical radiomics or clinical variables alone (p=4.64×10-14 and 4.57×10-22, respectively). iGray had a wide dose range (21.1-277 Gy, BED), suggested dose reduction in 23.3% of patients and can be safely delivered in the majority of cases. Voxel saliency maps indicate that 37.4% of the voxels that are most deterministic for treatment failure localize outside of the physician-contoured tumor volume.

Conclusion: Our image-based deep learning framework is the first opportunity to use medical images to individualize radiation dose delivery.

Author Disclosure: B. Lou: None. S. Doken: None. T. Zhuang: None. D. Wingerter: None. M. Abazeed: Research Grant; Bayer, Siemens Healthcare. Honoraria; Bayer. Travel Expenses; Bayer.

Mohamed Abazeed, MD, PhD

Cleveland Clinic Taussig Cancer Institute

Cleveland Clinic: Assistant Professor: Employee

Bayer: Honoraria: Research Grants: Travel Expenses;
Siemens Healthcare: Research Grants

My laboratory seeks to leverage the ongoing development of comprehensive cancer diagnostic tests that represent a critical step toward individualized cancer care by helping physicians recommend treatments based on the molecular and imaging profiles of individual tumors. Every project in the laboratory is committed to more “precise” cancer therapies as greater precision translates to improved responses in patients and less treatment-related toxicity. We demonstrate this commitment though projects that seek to enhance our understanding of targetable genetic alterations in the genome (functional genomics), the appreciation and delineation of inter- and intra-tumoral heterogeneity and the development of imaging deep learning/AI frameworks that individualize anti-cancer treatments.


Send Email for Mohamed Abazeed


195 - An Image-Based Framework for Individualizing Radiotherapy Dose

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for An Image-Based Framework for Individualizing Radiotherapy Dose